BackDicerna Pharmaceuticals Overview
Dicerna Pharmaceuticals Inc

Dicerna Pharmaceuticals Discounted Cash Flow

DCF Analysis for DRNA.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$39.91

Current Fair Value

$39.91
4.4% Upside

Undervalued by 4.4% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading